Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Naylor

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Thrombosis Research|April 15, 1993
Inhibition of thrombin and other trypsin-like serine proteinases by cyclotheonamide AS D Lewis, A S Ng, J J Baldwin, et al.
British Journal of Pharmacology|June 1, 1996
Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studiesB A Kenny, A M Miller, I J Williamson, et al.
Urology|July 1, 1994
Effect of alpha 1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dogB A Kenny, A M Naylor, A J Carter, et al.
British Journal of Pharmacology|April 1, 1994
Pharmacological properties of the cloned alpha 1A/D-adrenoceptor subtype are consistent with the alpha 1A-adrenoceptor characterized in rat cerebral cortex and vas deferensB A Kenny, A M Naylor, P M Greengrass, et al.
Brain Research|December 30, 1985
Vasopressin-induced motor disturbances: localization of a sensitive forebrain site in the ratA M Naylor, W D Ruwe, D M Burnard, et al.
International Journal of Impotence Research|June 1, 1996
Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunctionM Boolell, M J Allen, S A Ballard, et al.
Journal of Biomolecular NMR|May 1, 1994
Three-dimensional structure of echistatin and dynamics of the active siteY Chen, A K Suri, D Kominos, et al.
Biopolymers|August 1, 1993
The solution conformation of Ac-Pen-Arg-Gly-Asp-Cys-OH, a potent fibrinogen receptor antagonistM J Bogusky, A M Naylor, M E Mertzman, et al.
International Journal of Peptide and Protein Research|January 1, 1992
NMR and molecular modeling characterization of RGD containing peptidesM J Bogusky, A M Naylor, S M Pitzenberger, et al.
Journal of Medicinal Chemistry|April 17, 1998
Design of novel, potent, noncovalent inhibitors of thrombin with nonbasic P-1 substructures: rapid structure-activity studies by solid-phase synthesisW C Lumma, K M Witherup, T J Tucker, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Thrombosis Research|April 15, 1993
Inhibition of thrombin and other trypsin-like serine proteinases by cyclotheonamide AS D Lewis, A S Ng, J J Baldwin, et al.
British Journal of Pharmacology|June 1, 1996
Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studiesB A Kenny, A M Miller, I J Williamson, et al.
Urology|July 1, 1994
Effect of alpha 1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dogB A Kenny, A M Naylor, A J Carter, et al.
British Journal of Pharmacology|April 1, 1994
Pharmacological properties of the cloned alpha 1A/D-adrenoceptor subtype are consistent with the alpha 1A-adrenoceptor characterized in rat cerebral cortex and vas deferensB A Kenny, A M Naylor, P M Greengrass, et al.
Brain Research|December 30, 1985
Vasopressin-induced motor disturbances: localization of a sensitive forebrain site in the ratA M Naylor, W D Ruwe, D M Burnard, et al.
International Journal of Impotence Research|June 1, 1996
Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunctionM Boolell, M J Allen, S A Ballard, et al.
Journal of Biomolecular NMR|May 1, 1994
Three-dimensional structure of echistatin and dynamics of the active siteY Chen, A K Suri, D Kominos, et al.
Biopolymers|August 1, 1993
The solution conformation of Ac-Pen-Arg-Gly-Asp-Cys-OH, a potent fibrinogen receptor antagonistM J Bogusky, A M Naylor, M E Mertzman, et al.
International Journal of Peptide and Protein Research|January 1, 1992
NMR and molecular modeling characterization of RGD containing peptidesM J Bogusky, A M Naylor, S M Pitzenberger, et al.
Journal of Medicinal Chemistry|April 17, 1998
Design of novel, potent, noncovalent inhibitors of thrombin with nonbasic P-1 substructures: rapid structure-activity studies by solid-phase synthesisW C Lumma, K M Witherup, T J Tucker, et al.
Pageof 6